SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-16-006735
Filing Date
2016-08-12
Accepted
2016-08-12 16:23:35
Documents
66
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q s103860_10q.htm 10-Q 412701
2 EXHIBIT 10-1 s103860_ex10-1.htm EX-10.1 131818
3 EXHIBIT 31.1 s103860_ex31-1.htm EX-31.1 9250
4 EXHIBIT 31.2 s103860_ex31-2.htm EX-31.2 9176
5 EXHIBIT 32.1 s103860_ex32-1.htm EX-32.1 4090
6 EXHIBIT 32.2 s103860_ex32-2.htm EX-32.2 4700
  Complete submission text file 0001615774-16-006735.txt   3924730

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE enum-20160630.xml EX-101.INS 691327
8 XBRL SCHEMA FILE enum-20160630.xsd EX-101.SCH 36180
9 XBRL CALCULATION FILE enum-20160630_cal.xml EX-101.CAL 52860
10 XBRL DEFINITION FILE enum-20160630_def.xml EX-101.DEF 210939
11 XBRL LABEL FILE enum-20160630_lab.xml EX-101.LAB 326550
12 XBRL PRESENTATION FILE enum-20160630_pre.xml EX-101.PRE 294809
Mailing Address 200 CAMBRIDGEPARK DRIVE, SUITE 2000 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGEPARK DRIVE, SUITE 2000 CAMBRIDGE MA 02140 (617) 674-1865
Enumeral Biomedical Holdings, Inc. (Filer) CIK: 0001561551 (see all company filings)

IRS No.: 990376434 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55415 | Film No.: 161828512
SIC: 2834 Pharmaceutical Preparations